HLVX

2.14 +0.05 (+2.39%)

HilleVax, Inc · NASDAQ

Performance

+8.08%

1W

+6.47%

1M

+20.9%

3M

-84.78%

6M

+3.38%

YTD

-86.06%

1Y

Profile

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Technical Analysis of HLVX 2025-01-07

The stock exhibits a generally bullish sentiment with a Moving Average Score of 70 indicating strong upward momentum, while the Oscillators Score of 56 suggests a neutral stance that could lead to consolidation. Overall, the Technical Score of 63 reinforces a positive outlook, signaling potential for continued strength in the stock's performance.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of HLVX

Created with Highcharts 11.1.08866747431310100
QualityGrowthMomentumValue4

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.